Despite significant improvements in leprosy (Hansen's disease) treatment and outlook for
patients since the introduction of multidrug therapy (MDT) 3 decades ago, the global …

Mycobacterium leprae is known to cause leprosy, a neurological and dermatological
disease. In the past 20 years, 16 million leprosy cases have been recorded and more than …

Leprosy is a chronic and debilitating human disease caused by infection with the
Mycobacterium leprae bacillus. Despite the marked reduction in the number of registered …

Household contacts of leprosy patients are the group with the highest risk of developing the
disease, and although many risk or prevention factors have been identified, they have not …

Leprosy is a curable disease with well-defined etiology, but lacks better diagnostic tools,
preventive and therapeutic strategies. The continued application of the Ridley–Jopling …

ABSTRACT A simple serodiagnostic test based on the Mycobacterium leprae-specific
phenolic glycolipid I (PGL-I), for individuals with leprosy is nearly universally positive in …

Leprosy is a chronic infectious condition caused by Mycobacterium leprae (M. leprae). It is
endemic in many regions of the world and a public health problem in Brazil. Additionally, it …

Although leprosy is curable with drug treatment, the identification of biomarkers of infection,
disease progression and treatment efficacy would greatly help to reduce the overall …

Background Leprosy is a chronic infectious disease caused by Mycobacterium leprae that
can manifest a wide variety of immunological and clinical outcomes ranging from potent …

Background Despite efforts to eliminate leprosy as public health problem, delayed diagnosis
and disabilities still occur in many countries. Leprosy diagnosis remains based on clinical …